Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, C., Marschall, H. U., Karlsen, T. H., Melum, E., Kaser, A., Eksteen, B., Strazzabosco, M., Manns, M., & Trauner, M. (2014). Characterization of animal models for primary sclerosing cholangitis (PSC). Journal of Hepatology, 60, 1290–1303.

Article  PubMed  PubMed Central  Google Scholar 

Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013). Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology, 145, 521–536.

Article  CAS  PubMed  Google Scholar 

Lindor, K. D., Kowdley, K. V., Luketic, V. A., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Mooney, J., Sargeant, C., Braaten, J., Bernard, T., King, D., Miceli, E., Schmoll, J., Hoskin, T., Thapa, P., & Enders, F. (2009). High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 50, 808–814.

Article  CAS  PubMed  Google Scholar 

Giljaca, V., Poropat, G., Stimac, D., & Gluud, C. (2010). Glucocorticosteroids for primary sclerosing cholangitis. The Cochrane Database of Systematic Reviews, 2010, Cd004036.

PubMed  PubMed Central  Google Scholar 

Mousavere, I., Kalampokis, G., Fousekis, F., Karayiannis, P., Baltayiannis, G., & Christodoulou, D. (2023). An overview of recent treatment options for primary sclerosing cholangitis. Annals of Gastroenterology, 36, 589–598.

PubMed  PubMed Central  Google Scholar 

Tan, N., Lubel, J., Kemp, W., Roberts, S., & Majeed, A. (2023). Current therapeutics in primary sclerosing cholangitis. Journal of Clinical and Translational Hepatology, 11, 1267–1281.

PubMed  PubMed Central  Google Scholar 

Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H. U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., Schrumpf, E., Nevens, F., Trivedi, P., Reiter, F. P., Tornai, I., Halilbasic, E., Greinwald, R., Pröls, M., Manns, M. P., & Trauner, M. (2017). norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis. Journal of Hepatology, 67, 549–558.

Article  CAS  PubMed  Google Scholar 

Kowdley, K. V., Vuppalanchi, R., Levy, C., Floreani, A., Andreone, P., LaRusso, N. F., Shrestha, R., Trotter, J., Goldberg, D., Rushbrook, S., Hirschfield, G. M., Schiano, T., Jin, Y., Pencek, R., MacConell, L., Shapiro, D., & Bowlus, C. L. (2020). A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis. Journal of Hepatology, 73, 94–101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariotti, V., Strazzabosco, M., Fabris, L., & Calvisi, D. F. (2018). Animal models of biliary injury and altered bile acid metabolism. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1864, 1254–1261.

Article  CAS  PubMed  Google Scholar 

Pose, E., Sancho-Bru, P. & Coll, M. (2019). 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research. Methods in Molecular Biology, 1981, 249–257.

Article  CAS  PubMed  Google Scholar 

Wen, M., Liu, Y., Chen, R., He, P., Wu, F., Li, R., & Lin, Y. (2021). Geniposide suppresses liver injury in a mouse model of DDC‐induced sclerosing cholangitis. Phytotherapy Research, 35, 3799–3811.

Article  CAS  PubMed  Google Scholar 

Xu, L., Sheng, T., Liu, X., Zhang, T., Wang, Z., & Han, H. (2017). Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes. Journal of Ethnopharmacology, 209, 91–99.

Article  PubMed  Google Scholar 

Guo, Y., Pope, C., Cheng, X., Zhou, H., & Klaassen, C. D. (2011). Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. Journal of Ethnopharmacology, 138, 111–118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kulkarni, S., & Dhir, A. (2010). Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 24, 317–324.

Article  CAS  Google Scholar 

Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010). Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opinion on Investigational Drugs, 19, 1297–1307.

Article  CAS  PubMed  Google Scholar 

Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2010) Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evidence-Based Complementary and Alternative Medicine. 2011, 1–10.

Malkani, N., Sohail, M. I., Ijaz, F., Naeem, A., Mumtaz, S., & Saeed, Z. (2022). Berberis aristata reduces vancomycin-induced nephrotoxicity by down-regulation of cell proliferation markers. Journal of Herbal Medicine, 31, 100540.

Article  Google Scholar 

Zhang, Z., Li, B., Meng, X., Yao, S., Jin, L., Yang, J., Wang, J., Zhang, H., Zhang, Z., Cai, D., Zhang, Y. & Ning, G. (2016). Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Scientific Reports, 6, 20848.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Liu, X., Wang, L., Tan, S., Chen, Z., Wu, B. & Wu, X. (2022). Therapeutic effects of berberine on liver fibrosis are associated With lipid metabolism and intestinal flora. Frontiers in Pharmacology, 13, 814871.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phogat, A., Singh, J., Kumar, V. & Malik, V. (2023). Berberine mitigates acetamiprid-induced hepatotoxicity and inflammation via regulating endogenous antioxidants and NF-κB/TNF-α signaling in rats. Environmental Science and Pollution Research International, 30, 87412–87423.

Article  CAS  PubMed  Google Scholar 

Akhzari, M., Jalili, S., Rashno, S., Akmali, M., Foruozandeh, H. & Barazesh, M. (2024). Evaluation of the antioxidant effects of berberine against sodium nitriteinduced oxidative injury in the rat liver. Current Drug Safety, 19, 51–60.

Article  CAS  PubMed  Google Scholar 

Wang, L., Yan, Y., Wu, L. & Peng, J. (2023). Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development. Pharmacological Research, 196, 106925.

Article  CAS  PubMed  Google Scholar 

Bu, P., Le, Y., Zhang, Y., Zhang, Y. & Cheng, X. (2017). Berberine-induced inactivation of signal transducer and activator of transcription 5 signaling promotes male-specific expression of a bile acid uptake transporter. Journal of Biological Chemistry, 292, 4602–4613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadeghi, H., Azarmehr, N., Razmkhah, F., Sadeghi, H., Danaei, N., Omidifar, N., Vakilpour, H., Pourghadamyari, H., & Doustimotlagh, A. H. (2019). The hydroalcoholic extract of watercress attenuates protein oxidation, oxidative stress, and liver damage after bile duct ligation in rats. Journal of Cellular Biochemistry, 120, 14875–14884.

Article  CAS  PubMed  Google Scholar 

Sohail, I., Malkani, N., Tahir, N., Khalil, A., Attar, R., & Mumtaz, S. (2022). Silymarin protects the liver from α-naphthylisothiocyanate-induced cholestasis by modulating the expression of genes involved in bile acid homeostasis: anti-cholestatic effect of silymarin. Cellular and Molecular Biology, 68, 208–212.

Article  PubMed  Google Scholar 

Malkani, N., Naeem, A., Ijaz, F., Mumtaz, S., Ashraf, S. & Sohail, M. I. (2020). Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis. Molecular Biology Reports, 47, 5451–5459.

Article  CAS  PubMed  Google Scholar 

Li, Y. F., Wu, J. S., Li, Y. Y., Dai, Y., Zheng, M., Zeng, J. K., Wang, G. F., Wang, T. M., Li, W. K., Zhang, X. Y., Gu, M., Huang, C., Yang, L., Wang, Z. T., & Ma, Y. M. (2017). Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice. Oncotarget, 8, 97137–97152.

Article  PubMed  PubMed Central  Google Scholar 

Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28, 235–242.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biovia, D. S. (2021) BIOVIA Discovery Studio Academic Research Suite. San Diego: Dassault Systèmes.

Kaplan, W., & Littlejohn, T. G. (2001). Swiss-PDB viewer (deep view). Briefings in Bioinformatics, 2, 195–197.

Article  CAS  PubMed  Google Scholar 

Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand‐receptor docking. Current Protocols In Bioinformatics, 24, 8.14. 11–18.14. 40.

Article  Google Scholar 

Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., & Yu, B. (2019). PubChem 2019 update: improved access to chemical data. Nucleic Acids Research, 47, D1102–D1109.

Article  PubMed  Google Scholar 

O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open babel: an open chemical toolbox. Journal of Cheminformatics, 3, 1–14.

Google Scholar 

Jász, Á., Rák, Á., Ladjánszki, I., & Cserey, G. (2019). Optimized GPU implementation of Merck molecular force field and universal force field. Journal of Molecular Structure, 1188, 227–233.

Article  ADS  Google Scholar 

López-Blanco, J. R., Aliaga, J. I., Quintana-Ortí, E. S., & Chacón, P. (2014). iMODS: internal coordinates normal mode analysis server. Nucleic Acids Research, 42, W271–W276.

Article  PubMed  PubMed Central